Risk assessment in ART and implications for the EU directives on tissue and cells

Published 01 April 2019

Richard McGeehan, Legal Officer of DG Santé at the European Commission, considers the implications of the EURO-GTP risk assessment instrument for ART and its relevance to updates in the Tissue & Cell Directives of 2004.